Clinical outcomes with neoadjuvant versus adjuvant chemotherapy for triple negative breast cancer: A report from the National Cancer Database
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Clinical outcomes with neoadjuvant versus adjuvant chemotherapy for triple negative breast cancer: A report from the National Cancer Database
Authors
Keywords
Cancer treatment, Adjuvant chemotherapy, Breast cancer, Chemotherapy, Surgical and invasive medical procedures, Cancer detection and diagnosis, Insurance, Cancer chemotherapy
Journal
PLoS One
Volume 14, Issue 9, Pages e0222358
Publisher
Public Library of Science (PLoS)
Online
2019-09-20
DOI
10.1371/journal.pone.0222358
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Neoadjuvant Chemotherapy Use in Breast Cancer is Greatest in Excellent Responders: Triple-Negative and HER2+ Subtypes
- (2018) Brittany L. Murphy et al. ANNALS OF SURGICAL ONCOLOGY
- Adjuvant versus neoadjuvant chemotherapy in triple-negative breast cancer patients with BRCA mutations
- (2018) Katherine Clifton et al. BREAST CANCER RESEARCH AND TREATMENT
- Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials
- (2018) Bernard Asselain et al. LANCET ONCOLOGY
- Talazoparib in Patients with Advanced Breast Cancer and a Germline BRCA Mutation
- (2018) Jennifer K. Litton et al. NEW ENGLAND JOURNAL OF MEDICINE
- Long-Term Prognostic Risk After Neoadjuvant Chemotherapy Associated With Residual Cancer Burden and Breast Cancer Subtype
- (2017) W. Fraser Symmans et al. JOURNAL OF CLINICAL ONCOLOGY
- Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA Mutation
- (2017) Mark Robson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Adjuvant Capecitabine for Breast Cancer after Preoperative Chemotherapy
- (2017) Norikazu Masuda et al. NEW ENGLAND JOURNAL OF MEDICINE
- Evaluation of the Quality of Adjuvant Endocrine Therapy Delivery for Breast Cancer Care in the United States
- (2017) Bobby Daly et al. JAMA Oncology
- National Trends in the Use of Neoadjuvant Chemotherapy for Hormone Receptor-Negative Breast Cancer: A National Cancer Data Base Study
- (2016) Carlos A. Puig et al. ANNALS OF SURGICAL ONCOLOGY
- Abstract S2-05: Event-free and overall survival following neoadjuvant weekly paclitaxel and dose-dense AC +/- carboplatin and/or bevacizumab in triple-negative breast cancer: Outcomes from CALGB 40603 (Alliance)
- (2016) WM Sikov et al. CANCER RESEARCH
- Features of triple-negative breast cancer
- (2016) Magdalena L. Plasilova et al. MEDICINE
- Refinement of Triple-Negative Breast Cancer Molecular Subtypes: Implications for Neoadjuvant Chemotherapy Selection
- (2016) Brian D. Lehmann et al. PLoS One
- Use of neoadjuvant chemotherapy for patients with stage I to III breast cancer in the United States
- (2015) Sarah S. Mougalian et al. CANCER
- Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis
- (2014) Patricia Cortazar et al. LANCET
- Differential Response to Neoadjuvant Chemotherapy Among 7 Triple-Negative Breast Cancer Molecular Subtypes
- (2013) H. Masuda et al. CLINICAL CANCER RESEARCH
- Prognostic significance of subtype and pathologic response in operable breast cancer; a pooled analysis of prospective neoadjuvant studies of JBCRG
- (2013) Katsumasa Kuroi et al. Breast Cancer
- Definition and Impact of Pathologic Complete Response on Prognosis After Neoadjuvant Chemotherapy in Various Intrinsic Breast Cancer Subtypes
- (2012) Gunter von Minckwitz et al. JOURNAL OF CLINICAL ONCOLOGY
- Neoadjuvant Chemotherapy Is Associated with Improved Survival Compared with Adjuvant Chemotherapy in Patients with Triple-Negative Breast Cancer Only after Complete Pathologic Response
- (2011) Carla S. Fisher et al. ANNALS OF SURGICAL ONCOLOGY
- Neoadjuvant Versus Adjuvant Chemotherapy for Triple Negative Breast Cancer
- (2010) Carlie R. Kennedy et al. JOURNAL OF SURGICAL RESEARCH
- Response to Neoadjuvant Therapy and Long-Term Survival in Patients With Triple-Negative Breast Cancer
- (2008) Cornelia Liedtke et al. JOURNAL OF CLINICAL ONCOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now